These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 23942307

  • 1. Vaccinia virus outperforms a panel of other poxviruses as a potent oncolytic agent for the control of head and neck squamous cell carcinoma cell lines.
    Nichols AC, Yoo J, Um S, Mundi N, Palma DA, Fung K, Macneil SD, Koropatnick J, Mymryk JS, Barrett JW.
    Intervirology; 2014; 57(1):17-22. PubMed ID: 23942307
    [Abstract] [Full Text] [Related]

  • 2. The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses.
    Mundi N, Um S, Yoo J, Rizzo G, Black M, Pinto N, Palma DA, Fung K, MacNeil D, Mymryk JS, Barrett JW, Nichols AC.
    Virus Res; 2014 Sep 22; 190():53-9. PubMed ID: 25038405
    [Abstract] [Full Text] [Related]

  • 3. Oncolytic properties of non-vaccinia poxviruses.
    Ricordel M, Foloppe J, Pichon C, Findeli A, Tosch C, Cordier P, Cochin S, Quémeneur E, Camus-Bouclainville C, Bertagnoli S, Erbs P.
    Oncotarget; 2018 Nov 13; 9(89):35891-35906. PubMed ID: 30542506
    [Abstract] [Full Text] [Related]

  • 4. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
    Tysome JR, Wang P, Alusi G, Briat A, Gangeswaran R, Wang J, Bhakta V, Fodor I, Lemoine NR, Wang Y.
    Hum Gene Ther; 2011 Sep 13; 22(9):1101-8. PubMed ID: 21361787
    [Abstract] [Full Text] [Related]

  • 5. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
    Toivonen R, Suominen E, Grenman R, Savontaus M.
    Oncol Rep; 2009 Jan 13; 21(1):165-71. PubMed ID: 19082458
    [Abstract] [Full Text] [Related]

  • 6. Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines.
    Nichols AC, Yoo J, Palma DA, Fung K, Franklin JH, Koropatnick J, Mymryk JS, Batada NN, Barrett JW.
    Arch Otolaryngol Head Neck Surg; 2012 Aug 13; 138(8):732-9. PubMed ID: 22911296
    [Abstract] [Full Text] [Related]

  • 7. Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus.
    Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y.
    J Am Coll Surg; 2001 Jul 13; 193(1):12-21. PubMed ID: 11442249
    [Abstract] [Full Text] [Related]

  • 8. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
    Haddad D, Chen N, Zhang Q, Chen CH, Yu YA, Gonzalez L, Aguilar J, Li P, Wong J, Szalay AA, Fong Y.
    Ann Surg Oncol; 2012 Jul 13; 19 Suppl 3():S665-74. PubMed ID: 22258815
    [Abstract] [Full Text] [Related]

  • 9. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.
    Eur J Cancer; 2005 Jan 13; 41(2):313-22. PubMed ID: 15661558
    [Abstract] [Full Text] [Related]

  • 10. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D, Duan L, Freimuth P, O'Malley BW.
    Clin Cancer Res; 1999 Dec 13; 5(12):4175-81. PubMed ID: 10632357
    [Abstract] [Full Text] [Related]

  • 11. Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses.
    Reddy PS, Ganesh S, Yu DC.
    Clin Cancer Res; 2006 May 01; 12(9):2869-78. PubMed ID: 16675583
    [Abstract] [Full Text] [Related]

  • 12. Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions.
    van Zeeburg HJ, Huizenga A, Brink A, van den Doel PB, Zhu ZB, McCormick F, Brakenhoff RH, van Beusechem VW.
    Gene Ther; 2010 Dec 01; 17(12):1517-24. PubMed ID: 20686507
    [Abstract] [Full Text] [Related]

  • 13. Fusogenic vesicular stomatitis virus for the treatment of head and neck squamous carcinomas.
    Shin EJ, Chang JI, Choi B, Wanna G, Ebert O, Genden EM, Woo SL.
    Otolaryngol Head Neck Surg; 2007 May 01; 136(5):811-7. PubMed ID: 17478221
    [Abstract] [Full Text] [Related]

  • 14. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.
    Heiduschka G, Erovic BM, Vormittag L, Skoda C, Martinek H, Brunner M, Ehrenberger K, Thurnher D.
    Arch Otolaryngol Head Neck Surg; 2009 Mar 01; 135(3):261-7. PubMed ID: 19289704
    [Abstract] [Full Text] [Related]

  • 15. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
    Sung CK, Choi B, Wanna G, Genden EM, Woo SL, Shin EJ.
    Laryngoscope; 2008 Feb 01; 118(2):237-42. PubMed ID: 18043494
    [Abstract] [Full Text] [Related]

  • 16. AZD5582, an IAP antagonist that leads to apoptosis in head and neck squamous cell carcinoma cell lines and is eligible for combination with irradiation.
    Kadletz L, Enzenhofer E, Kotowski U, Altorjai G, Heiduschka G.
    Acta Otolaryngol; 2017 Mar 01; 137(3):320-325. PubMed ID: 27739348
    [Abstract] [Full Text] [Related]

  • 17. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
    Dias JD, Liikanen I, Guse K, Foloppe J, Sloniecka M, Diaconu I, Rantanen V, Eriksson M, Hakkarainen T, Lusky M, Erbs P, Escutenaire S, Kanerva A, Pesonen S, Cerullo V, Hemminki A.
    Clin Cancer Res; 2010 May 01; 16(9):2540-9. PubMed ID: 20388844
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
    Kondo N, Tsukuda M, Kimura M, Fujita K, Sakakibara A, Takahashi H, Ishiguro Y, Toth G, Matsuda H.
    Oncol Rep; 2010 Feb 01; 23(2):355-63. PubMed ID: 20043095
    [Abstract] [Full Text] [Related]

  • 19. Telomerase-specific virotheranostics for human head and neck cancer.
    Kurihara Y, Watanabe Y, Onimatsu H, Kojima T, Shirota T, Hatori M, Liu D, Kyo S, Mizuguchi H, Urata Y, Shintani S, Fujiwara T.
    Clin Cancer Res; 2009 Apr 01; 15(7):2335-43. PubMed ID: 19318473
    [Abstract] [Full Text] [Related]

  • 20. Telomerase-specific virotherapy for human squamous cell carcinoma.
    Fujiwara T.
    Expert Opin Biol Ther; 2009 Mar 01; 9(3):321-9. PubMed ID: 19216621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.